| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 5.29e-10 | 11 | 84 | 5 | GO:0015217 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 2.27e-09 | 14 | 84 | 5 | GO:0005347 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 9.68e-09 | 37 | 84 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.15e-08 | 38 | 84 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 3.70e-08 | 23 | 84 | 5 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 7.17e-08 | 26 | 84 | 5 | GO:0000295 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 9.40e-08 | 11 | 84 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.28e-07 | 29 | 84 | 5 | GO:0015216 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.74e-07 | 59 | 84 | 6 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.74e-07 | 59 | 84 | 6 | GO:0015932 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 2.53e-07 | 33 | 84 | 5 | GO:0015215 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.82e-07 | 14 | 84 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.26e-07 | 38 | 84 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 6.01e-07 | 39 | 84 | 5 | GO:0015605 | |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 7.14e-07 | 5 | 84 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.65e-06 | 21 | 84 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MMAA DHX36 KIF6 ATP8A1 RUVBL1 DNAH10 ABCA12 PSMC6 KIF3C SNRNP200 | 1.60e-05 | 441 | 84 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.73e-05 | 37 | 84 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 2.06e-05 | 79 | 84 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A GABRR1 CACNA1E SLC25A41 SLC25A42 SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC25A6 ABCA12 SLC22A1 SCN3A UNC80 GABRA4 | 2.83e-05 | 1180 | 84 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.16e-05 | 46 | 84 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MMAA DHX36 KIF6 ATP8A1 RUVBL1 DNAH10 MYO7A ABCA12 PSMC6 KIF3C SNRNP200 | 5.16e-05 | 614 | 84 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A GABRR1 CACNA1E SLC25A41 SLC25A42 SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC25A6 ABCA12 SLC22A1 SCN3A UNC80 GABRA4 | 8.14e-05 | 1289 | 84 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A GABRR1 CACNA1E SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC22A1 SCN3A UNC80 GABRA4 | 1.16e-04 | 793 | 84 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.18e-04 | 262 | 84 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 1.73e-04 | 5 | 84 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 1.73e-04 | 5 | 84 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MMAA DHX36 KIF6 SLC25A42 ATP8A1 RUVBL1 DNAH10 ABCA12 LRRK2 PSMC6 KIF3C SNRNP200 | 1.96e-04 | 839 | 84 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MMAA DHX36 KIF6 SLC25A42 ATP8A1 RUVBL1 DNAH10 ABCA12 LRRK2 PSMC6 KIF3C SNRNP200 | 1.98e-04 | 840 | 84 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MMAA DHX36 KIF6 SLC25A42 ATP8A1 RUVBL1 DNAH10 ABCA12 LRRK2 PSMC6 KIF3C SNRNP200 | 1.98e-04 | 840 | 84 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.35e-04 | 293 | 84 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.73e-04 | 136 | 84 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.73e-04 | 136 | 84 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 3.69e-04 | 417 | 84 | 8 | GO:0140098 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | BUD23 ERVK-6 DHX36 RUVBL1 RCL1 ERVK-8 ERVK-7 ERVK-10 REV3L SNRNP200 | 3.70e-04 | 645 | 84 | 10 | GO:0140640 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MMAA DHX36 KIF6 ATP8A1 RUVBL1 DNAH10 ABCA12 LRRK2 PSMC6 KIF3C SNRNP200 | 3.94e-04 | 775 | 84 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 4.55e-04 | 152 | 84 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A CACNA1E SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC22A1 SCN3A UNC80 | 4.65e-04 | 664 | 84 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 6.18e-04 | 9 | 84 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 6.18e-04 | 9 | 84 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | pre-miRNA binding | 6.18e-04 | 9 | 84 | 2 | GO:0070883 | |
| GeneOntologyMolecularFunction | G-quadruplex RNA binding | 7.70e-04 | 10 | 84 | 2 | GO:0002151 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 7.70e-04 | 10 | 84 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC25A42 SLC4A8 ATP8A1 SLC25A4 SLC25A5 SLC25A6 ABCA12 SLC22A1 | 8.91e-04 | 477 | 84 | 8 | GO:0022804 |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 9.38e-04 | 11 | 84 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | ADP binding | 1.08e-03 | 48 | 84 | 3 | GO:0043531 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A GABRR1 CACNA1E SLC4A8 SLC25A4 SLC25A5 TRPM3 SLC22A1 SCN3A GABRA4 | 1.28e-03 | 758 | 84 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.54e-03 | 14 | 84 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.55e-03 | 118 | 84 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.56e-03 | 296 | 84 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.92e-03 | 125 | 84 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.23e-03 | 430 | 84 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.56e-03 | 18 | 84 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.75e-03 | 138 | 84 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 2.85e-03 | 19 | 84 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.92e-03 | 231 | 84 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | NAD+ binding | 3.16e-03 | 20 | 84 | 2 | GO:0070403 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.20e-03 | 459 | 84 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.21e-03 | 70 | 84 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 3.80e-03 | 151 | 84 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 3.82e-03 | 22 | 84 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 3.82e-03 | 22 | 84 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 3.88e-03 | 247 | 84 | 5 | GO:0000287 | |
| GeneOntologyMolecularFunction | cyclase activity | 4.54e-03 | 24 | 84 | 2 | GO:0009975 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 4.85e-03 | 627 | 84 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 4.93e-03 | 25 | 84 | 2 | GO:0031683 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 5.32e-03 | 26 | 84 | 2 | GO:0097602 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.89e-03 | 171 | 84 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 RIOK1 MARK4 LRRK2 ERVK-8 ERVK-7 ERVK-10 MARK2 REV3L LYN | 5.91e-03 | 938 | 84 | 10 | GO:0016772 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 6.16e-03 | 28 | 84 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | peptidase activity | 6.22e-03 | 654 | 84 | 8 | GO:0008233 | |
| GeneOntologyMolecularFunction | channel activity | 6.62e-03 | 525 | 84 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.68e-03 | 526 | 84 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 6.76e-03 | 807 | 84 | 9 | GO:0016788 | |
| GeneOntologyMolecularFunction | laminin binding | 8.99e-03 | 34 | 84 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 8.99e-03 | 34 | 84 | 2 | GO:0008266 | |
| GeneOntologyMolecularFunction | tubulin binding | 9.34e-03 | 428 | 84 | 6 | GO:0015631 | |
| GeneOntologyMolecularFunction | microtubule binding | 9.68e-03 | 308 | 84 | 5 | GO:0008017 | |
| GeneOntologyBiologicalProcess | ADP transport | 8.17e-10 | 12 | 85 | 5 | GO:0015866 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 1.34e-09 | 5 | 85 | 4 | GO:0140021 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 1.40e-08 | 40 | 85 | 6 | GO:0072530 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 1.86e-08 | 8 | 85 | 4 | GO:1990544 | |
| GeneOntologyBiologicalProcess | ATP transport | 3.35e-08 | 23 | 85 | 5 | GO:0015867 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 1.65e-07 | 31 | 85 | 5 | GO:1901679 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.87e-07 | 13 | 85 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 6.20e-07 | 40 | 85 | 5 | GO:0015868 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 7.96e-07 | 42 | 85 | 5 | GO:0051503 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.01e-06 | 44 | 85 | 5 | GO:0015865 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.57e-06 | 48 | 85 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 1.93e-06 | 50 | 85 | 5 | GO:0006862 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DOCK2 DHX36 RIPOR2 ATP8A1 RUVBL1 PTPRF SLC25A4 SLC25A5 MARK4 LRRK2 CASP4 PSMC6 SPIRE1 MCRS1 KIF3C MARK2 CUL7 LYN TBX5 | 2.23e-06 | 1366 | 85 | 19 | GO:0051130 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 4.78e-06 | 162 | 85 | 7 | GO:0015748 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | ERVK-6 SLC25A41 SLC25A42 SLC25A4 SLC25A5 SLC25A6 XPO5 NUP210 | 8.71e-06 | 249 | 85 | 8 | GO:0015931 |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.67e-05 | 85 | 85 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.67e-05 | 85 | 85 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.97e-05 | 15 | 85 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | syncytium formation | 3.34e-05 | 89 | 85 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A GABRR1 CACNA1E IBTK SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC22A1 SCN3A PLCB2 LYN UNC80 GABRA4 | 4.56e-05 | 1115 | 85 | 15 | GO:0034220 |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 4.81e-05 | 96 | 85 | 5 | GO:1901264 | |
| GeneOntologyBiologicalProcess | organic anion transport | CACNA1A SLC25A41 SLC25A42 SLC4A8 SLC25A4 SLC25A5 SLC25A6 SLC22A1 CPT1B LYN | 5.05e-05 | 515 | 85 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 6.21e-05 | 165 | 85 | 6 | GO:1903305 | |
| GeneOntologyBiologicalProcess | mitochondrial transmembrane transport | 7.72e-05 | 106 | 85 | 5 | GO:1990542 | |
| GeneOntologyBiologicalProcess | positive regulation of cardioblast differentiation | 1.00e-04 | 4 | 85 | 2 | GO:0051891 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 1.13e-04 | 23 | 85 | 3 | GO:0035795 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A CACNA1E IBTK SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC22A1 SCN3A PLCB2 LYN UNC80 | 1.21e-04 | 942 | 85 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1.28e-04 | 24 | 85 | 3 | GO:1901028 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 1.64e-04 | 26 | 85 | 3 | GO:1905709 | |
| GeneOntologyBiologicalProcess | regulation of cardioblast differentiation | 1.66e-04 | 5 | 85 | 2 | GO:0051890 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 2.00e-04 | 291 | 85 | 7 | GO:0045055 | |
| GeneOntologyBiologicalProcess | adenine transport | 2.49e-04 | 6 | 85 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 2.84e-04 | 218 | 85 | 6 | GO:0071897 | |
| GeneOntologyBiologicalProcess | DNA replication | 3.05e-04 | 312 | 85 | 7 | GO:0006260 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 3.07e-04 | 32 | 85 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization | 3.37e-04 | 33 | 85 | 3 | GO:0097345 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | DHX36 RIPOR2 RUVBL1 SLC25A4 SLC25A5 SLC25A6 MARK4 LRRK2 CUL9 SPIRE1 MCRS1 MARK2 CUL7 GBA2 ZFY | 3.53e-04 | 1342 | 85 | 15 | GO:0033043 |
| GeneOntologyBiologicalProcess | microtubule-based process | CACNA1E KIF6 RIPOR2 IFT52 YIF1B DNAH10 MARK4 CUL9 SPIRE1 KIF3C MARK2 CUL7 GBA2 | 3.76e-04 | 1058 | 85 | 13 | GO:0007017 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.85e-04 | 83 | 85 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 4.02e-04 | 35 | 85 | 3 | GO:0007214 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 4.05e-04 | 233 | 85 | 6 | GO:0017157 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A GABRR1 CACNA1E IBTK SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC22A1 SCN3A PLCB2 LYN UNC80 GABRA4 | 4.53e-04 | 1374 | 85 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of mitochondrion organization | 5.56e-04 | 162 | 85 | 5 | GO:0010821 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 5.98e-04 | 40 | 85 | 3 | GO:1902110 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization involved in programmed cell death | 6.90e-04 | 42 | 85 | 3 | GO:1902686 | |
| GeneOntologyBiologicalProcess | positive regulation of rRNA processing | 7.39e-04 | 10 | 85 | 2 | GO:2000234 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy | 7.48e-04 | 173 | 85 | 5 | GO:0010508 | |
| GeneOntologyBiologicalProcess | DNA recombination | 8.14e-04 | 368 | 85 | 7 | GO:0006310 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability | 8.46e-04 | 45 | 85 | 3 | GO:0035794 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 8.50e-04 | 178 | 85 | 5 | GO:0006261 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CACNA1E IBTK SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC22A1 SCN3A PLCB2 LYN UNC80 | 8.70e-04 | 1157 | 85 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A GABRR1 CACNA1E IBTK SLC4A8 SLC25A4 SLC25A5 TRPM3 SCN3A PLCB2 LYN GABRA4 | 9.17e-04 | 1017 | 85 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 9.80e-04 | 494 | 85 | 8 | GO:0031346 | |
| GeneOntologyBiologicalProcess | purine nucleobase transport | 1.08e-03 | 12 | 85 | 2 | GO:0006863 | |
| GeneOntologyBiologicalProcess | acetylcholine transport | 1.08e-03 | 12 | 85 | 2 | GO:0015870 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability involved in apoptotic process | 1.09e-03 | 49 | 85 | 3 | GO:1902108 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane permeability | 1.15e-03 | 50 | 85 | 3 | GO:1905710 | |
| GeneOntologyCellularComponent | mitochondrial membrane | SLC25A41 SLC25A42 SLC25A4 SLC25A5 SLC25A6 ABCA12 GLUD1 LRRK2 SPIRE1 HADHA HMOX1 CPT1B LYN | 3.98e-05 | 866 | 84 | 13 | GO:0031966 |
| GeneOntologyCellularComponent | mitochondrial envelope | SLC25A41 SLC25A42 SLC25A4 SLC25A5 SLC25A6 ABCA12 GLUD1 LRRK2 SPIRE1 HADHA HMOX1 CPT1B LYN | 6.75e-05 | 912 | 84 | 13 | GO:0005740 |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1A DHX36 CACNA1E IFT52 SLC4A8 PTPRF SCN3A MARK4 LRRK2 CASP4 MCRS1 KIF3C MARK2 ADCY2 GABRA4 | 1.01e-04 | 1228 | 84 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | mitochondrial inner membrane | SLC25A41 SLC25A42 SLC25A4 SLC25A5 SLC25A6 ABCA12 GLUD1 LRRK2 HADHA LYN | 1.31e-04 | 593 | 84 | 10 | GO:0005743 |
| GeneOntologyCellularComponent | organelle inner membrane | SLC25A41 SLC25A42 SLC25A4 SLC25A5 SLC25A6 ABCA12 GLUD1 LRRK2 HADHA LYN | 2.81e-04 | 652 | 84 | 10 | GO:0019866 |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 3.31e-04 | 7 | 84 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | organelle envelope | SLC25A41 SLC25A42 SLC25A4 SLC25A5 SLC25A6 ABCA12 NUP210 GLUD1 LRRK2 INTS1 SPIRE1 HADHA HMOX1 CPT1B LYN | 5.44e-04 | 1435 | 84 | 15 | GO:0031967 |
| GeneOntologyCellularComponent | dendrite | CACNA1A DHX36 IFT52 SLC4A8 MARK4 LRRK2 MCRS1 KIF3C MARK2 ADCY2 GABRA4 | 6.29e-04 | 858 | 84 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1A DHX36 IFT52 SLC4A8 MARK4 LRRK2 MCRS1 KIF3C MARK2 ADCY2 GABRA4 | 6.42e-04 | 860 | 84 | 11 | GO:0097447 |
| Domain | Mit_carrier | 2.34e-07 | 32 | 80 | 5 | IPR002067 | |
| Domain | SOLCAR | 3.10e-06 | 53 | 80 | 5 | PS50920 | |
| Domain | - | 3.10e-06 | 53 | 80 | 5 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 3.10e-06 | 53 | 80 | 5 | IPR018108 | |
| Domain | Mito_carr | 3.10e-06 | 53 | 80 | 5 | PF00153 | |
| Domain | Mt_carrier_dom | 3.10e-06 | 53 | 80 | 5 | IPR023395 | |
| Domain | Aden_trnslctor | 5.91e-06 | 28 | 80 | 4 | IPR002113 | |
| Domain | Mit_uncoupling | 1.62e-05 | 12 | 80 | 3 | IPR002030 | |
| Domain | AAA+_ATPase | 3.56e-05 | 144 | 80 | 6 | IPR003593 | |
| Domain | AAA | 3.56e-05 | 144 | 80 | 6 | SM00382 | |
| Domain | Cul7 | 5.42e-05 | 3 | 80 | 2 | PF11515 | |
| Domain | CPH_domain | 5.42e-05 | 3 | 80 | 2 | IPR021097 | |
| Domain | ARM-type_fold | 1.01e-04 | 339 | 80 | 8 | IPR016024 | |
| Domain | MARK/par1 | 1.08e-04 | 4 | 80 | 2 | IPR033624 | |
| Domain | KA1_dom | 1.80e-04 | 5 | 80 | 2 | IPR001772 | |
| Domain | KA1 | 1.80e-04 | 5 | 80 | 2 | PF02149 | |
| Domain | KA1 | 1.80e-04 | 5 | 80 | 2 | PS50032 | |
| Domain | - | 1.80e-04 | 5 | 80 | 2 | 3.30.310.80 | |
| Domain | VDCC_a1su_IQ | 3.75e-04 | 7 | 80 | 2 | IPR014873 | |
| Domain | APC_su10/DOC_dom | 3.75e-04 | 7 | 80 | 2 | IPR004939 | |
| Domain | GPHH | 3.75e-04 | 7 | 80 | 2 | PF16905 | |
| Domain | DOC | 3.75e-04 | 7 | 80 | 2 | PS51284 | |
| Domain | KA1/Ssp2_C | 3.75e-04 | 7 | 80 | 2 | IPR028375 | |
| Domain | GPHH_dom | 3.75e-04 | 7 | 80 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 3.75e-04 | 7 | 80 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 3.75e-04 | 7 | 80 | 2 | PF08763 | |
| Domain | APC10 | 3.75e-04 | 7 | 80 | 2 | SM01337 | |
| Domain | ANAPC10 | 3.75e-04 | 7 | 80 | 2 | PF03256 | |
| Domain | Cullin_Nedd8 | 4.99e-04 | 8 | 80 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 4.99e-04 | 8 | 80 | 2 | SM00884 | |
| Domain | Cullin_neddylation_domain | 4.99e-04 | 8 | 80 | 2 | IPR019559 | |
| Domain | Cullin_homology | 6.40e-04 | 9 | 80 | 2 | IPR016158 | |
| Domain | Cullin | 7.97e-04 | 10 | 80 | 2 | PF00888 | |
| Domain | CULLIN_2 | 7.97e-04 | 10 | 80 | 2 | PS50069 | |
| Domain | VDCCAlpha1 | 7.97e-04 | 10 | 80 | 2 | IPR002077 | |
| Domain | Cullin_N | 7.97e-04 | 10 | 80 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 7.97e-04 | 10 | 80 | 2 | PS01256 | |
| Domain | BTB-kelch_protein | 8.25e-04 | 43 | 80 | 3 | IPR017096 | |
| Domain | P-loop_NTPase | MMAA DHX36 KIF6 RUVBL1 DNAH10 MYO7A ABCA12 LRRK2 PSMC6 KIF3C SNRNP200 | 9.47e-04 | 848 | 80 | 11 | IPR027417 |
| Domain | ARM-like | 1.06e-03 | 270 | 80 | 6 | IPR011989 | |
| Domain | Ion_trans_dom | 1.46e-03 | 114 | 80 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.46e-03 | 114 | 80 | 4 | PF00520 | |
| Domain | Channel_four-helix_dom | 1.87e-03 | 57 | 80 | 3 | IPR027359 | |
| Domain | - | 1.87e-03 | 57 | 80 | 3 | 1.20.120.350 | |
| Domain | Kelch | 1.97e-03 | 58 | 80 | 3 | SM00612 | |
| Domain | BACK | 2.17e-03 | 60 | 80 | 3 | SM00875 | |
| Domain | BACK | 2.28e-03 | 61 | 80 | 3 | PF07707 | |
| Domain | BACK | 2.28e-03 | 61 | 80 | 3 | IPR011705 | |
| Domain | SH3 | 2.35e-03 | 216 | 80 | 5 | SM00326 | |
| Domain | SH3 | 2.35e-03 | 216 | 80 | 5 | PS50002 | |
| Domain | BTB | 2.42e-03 | 131 | 80 | 4 | PF00651 | |
| Domain | SH3_domain | 2.54e-03 | 220 | 80 | 5 | IPR001452 | |
| Domain | - | 2.65e-03 | 222 | 80 | 5 | 1.25.10.10 | |
| Domain | Rib_L2_dom2 | 2.65e-03 | 18 | 80 | 2 | IPR014722 | |
| Domain | - | 2.65e-03 | 18 | 80 | 2 | 2.30.30.30 | |
| Domain | RCC1 | 3.27e-03 | 20 | 80 | 2 | PF00415 | |
| Domain | Kelch_1 | 3.37e-03 | 70 | 80 | 3 | PF01344 | |
| Domain | Kelch_1 | 3.37e-03 | 70 | 80 | 3 | IPR006652 | |
| Domain | RCC1_1 | 3.61e-03 | 21 | 80 | 2 | PS00625 | |
| Domain | RCC1_2 | 3.61e-03 | 21 | 80 | 2 | PS00626 | |
| Domain | RCC1_3 | 3.61e-03 | 21 | 80 | 2 | PS50012 | |
| Domain | Reg_chr_condens | 3.96e-03 | 22 | 80 | 2 | IPR000408 | |
| Domain | - | 3.96e-03 | 22 | 80 | 2 | 2.130.10.30 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 7.62e-08 | 23 | 69 | 5 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.53e-06 | 18 | 69 | 4 | M47659 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.40e-06 | 20 | 69 | 4 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.95e-06 | 21 | 69 | 4 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.60e-06 | 22 | 69 | 4 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.60e-06 | 22 | 69 | 4 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.34e-06 | 23 | 69 | 4 | M47676 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 1.31e-05 | 10 | 69 | 3 | M47694 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 2.39e-05 | 12 | 69 | 3 | M27728 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.54e-05 | 178 | 69 | 7 | M2890 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 3.07e-05 | 37 | 69 | 4 | M1029 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.10e-05 | 13 | 69 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 3.10e-05 | 13 | 69 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 3.10e-05 | 13 | 69 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 3.93e-05 | 14 | 69 | 3 | M47692 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 4.26e-05 | 131 | 69 | 6 | M5283 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 4.90e-05 | 15 | 69 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.00e-05 | 16 | 69 | 3 | M47695 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 7.49e-05 | 211 | 69 | 7 | MM14502 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 8.69e-05 | 18 | 69 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 1.03e-04 | 19 | 69 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.03e-04 | 19 | 69 | 3 | M47760 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC4A8 ATP8A1 SLC25A4 SLC25A5 TRPM3 SLC25A6 ABCA12 SLC22A1 PSMC6 HMOX1 ADCY2 UNC80 | 2.12e-04 | 736 | 69 | 12 | M27287 |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.21e-04 | 335 | 69 | 8 | MM14503 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.43e-04 | 270 | 69 | 7 | M15514 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 6.02e-04 | 34 | 69 | 3 | M210 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 8.61e-04 | 411 | 69 | 8 | M735 | |
| Pathway | REACTOME_HIV_INFECTION | 9.19e-04 | 231 | 69 | 6 | M12469 | |
| Pathway | BIOCARTA_ETC_PATHWAY | 1.04e-03 | 10 | 69 | 2 | M15371 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.20e-03 | 43 | 69 | 3 | M881 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.26e-03 | 11 | 69 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.26e-03 | 11 | 69 | 2 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.26e-03 | 11 | 69 | 2 | M47958 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.26e-03 | 11 | 69 | 2 | MM15471 | |
| Pubmed | 1.27e-09 | 7 | 87 | 4 | 21370995 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 1.51e-08 | 3 | 87 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 1.51e-08 | 3 | 87 | 3 | 2829183 | |
| Pubmed | DOCK2 SLC4A8 PER3 TULP4 TRPM3 NUP210 CUL7 GBA2 SNRNP200 UNC80 TBC1D9 | 4.41e-08 | 493 | 87 | 11 | 15368895 | |
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 33396658 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.04e-08 | 4 | 87 | 3 | 10469592 | |
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 7983737 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.40e-07 | 94 | 87 | 6 | 21542922 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.51e-07 | 5 | 87 | 3 | 12629516 | |
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 2.28e-07 | 53 | 87 | 5 | 23266187 | |
| Pubmed | 3.01e-07 | 6 | 87 | 3 | 10620603 | ||
| Pubmed | Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. | 3.74e-07 | 24 | 87 | 4 | 24725412 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TINAGL1 PTPRF TULP4 MYO7A KLHL36 UBR4 MARK4 INTS1 CUL9 SPIRE1 BCAM REV3L GBA2 TBC1D9 | 6.15e-07 | 1105 | 87 | 14 | 35748872 |
| Pubmed | DHX36 XPO5 UBR4 NUP210 RCL1 INTS1 CUL9 HADHA CUL7 SNRNP200 HERC5 | 7.23e-07 | 653 | 87 | 11 | 22586326 | |
| Pubmed | 7.45e-07 | 67 | 87 | 5 | 30669930 | ||
| Pubmed | 8.39e-07 | 8 | 87 | 3 | 27641616 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX36 RIOK1 RUVBL1 SLC25A4 SLC25A5 SLC25A6 XPO5 UBR4 GLUD1 RCL1 INTS1 PSMC6 HADHA LYN SNRNP200 | 8.97e-07 | 1318 | 87 | 15 | 30463901 |
| Pubmed | 1.17e-06 | 214 | 87 | 7 | 22199357 | ||
| Pubmed | 1.26e-06 | 9 | 87 | 3 | 24275721 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RUVBL1 PTPRF SLC25A5 SLC25A6 APMAP NUP210 GLUD1 INTS1 HADHA MARK2 CUL7 LYN SNRNP200 | 1.58e-06 | 1024 | 87 | 13 | 24711643 |
| Pubmed | 2.04e-06 | 82 | 87 | 5 | 20833797 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SLC25A5 TRPM3 MYO7A SCN3A UBR4 INTS1 HADHA REV3L CPT1B LYN SNRNP200 | 2.30e-06 | 736 | 87 | 11 | 29676528 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 RIOK1 RUVBL1 DNAH10 SLC25A5 XPO5 APMAP UBR4 NUP210 GLUD1 RCL1 PSMC6 KIF3C HADHA SNRNP200 | 2.35e-06 | 1425 | 87 | 15 | 30948266 |
| Pubmed | 2.47e-06 | 153 | 87 | 6 | 10718198 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DHX36 KLHL9 RUVBL1 SLC25A4 SLC25A5 SLC25A6 APMAP UBR4 NUP210 GLUD1 INTS1 PSMC6 HADHA SNRNP200 | 2.78e-06 | 1257 | 87 | 14 | 37317656 |
| Pubmed | 3.27e-06 | 12 | 87 | 3 | 16120388 | ||
| Pubmed | 3.27e-06 | 12 | 87 | 3 | 14557543 | ||
| Pubmed | Proteomic analysis of the mouse liver mitochondrial inner membrane. | 5.37e-06 | 175 | 87 | 6 | 12865426 | |
| Pubmed | DHX36 RUVBL1 SLC25A4 SLC25A5 SLC25A6 XPO5 SCN3A NUP210 PSMC6 PABPC1L HADHA LYN SNRNP200 | 5.75e-06 | 1153 | 87 | 13 | 29845934 | |
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 6.19e-06 | 2 | 87 | 2 | 10926541 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 16381801 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9060628 | ||
| Pubmed | Receptor for motilin identified in the human gastrointestinal system. | 6.19e-06 | 2 | 87 | 2 | 10381885 | |
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 6.19e-06 | 2 | 87 | 2 | 9460924 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 26842067 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 6.19e-06 | 2 | 87 | 2 | 14749836 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 27048932 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 16556444 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 2823266 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 35192892 | ||
| Pubmed | Demonstration of a functional motilin receptor in TE671 cells from human cerebellum. | 6.19e-06 | 2 | 87 | 2 | 11259768 | |
| Pubmed | The motilin pharmacophore in CHO cells expressing the human motilin receptor. | 6.19e-06 | 2 | 87 | 2 | 12054506 | |
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 6.19e-06 | 2 | 87 | 2 | 10974536 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 11461914 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 12112115 | ||
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 6.19e-06 | 2 | 87 | 2 | 11756613 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 27704316 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | DHX36 RIOK1 SLC25A5 SLC25A6 GLUD1 RCL1 HADHA MARK2 SNRNP200 HERC5 | 7.70e-06 | 678 | 87 | 10 | 30209976 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | BUD23 RUVBL1 SLC25A4 SLC25A5 SLC25A6 UBR4 PSMC6 BCAT1 HADHA SNRNP200 | 1.07e-05 | 704 | 87 | 10 | 29955894 |
| Pubmed | 1.33e-05 | 120 | 87 | 5 | 27320910 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.41e-05 | 313 | 87 | 7 | 38270169 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DHX36 IBTK RUVBL1 XPO5 UBR4 CASP4 PSMC6 SPIRE1 MCRS1 HADHA MARK2 LYN SNRNP200 | 1.80e-05 | 1284 | 87 | 13 | 17353931 |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 17229476 | ||
| Pubmed | Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development. | 1.85e-05 | 3 | 87 | 2 | 15964813 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 10516026 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 17298945 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 38996073 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 16875676 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 16831128 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.85e-05 | 3 | 87 | 2 | 24523520 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 9108484 | ||
| Pubmed | 2.02e-05 | 331 | 87 | 7 | 29199018 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DHX36 IBTK RUVBL1 SLC25A4 SLC25A6 RCL1 MARK2 CUL7 SNRNP200 HERC5 | 2.04e-05 | 759 | 87 | 10 | 35915203 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 2.58e-05 | 344 | 87 | 7 | 36282215 | |
| Pubmed | The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes. | 2.79e-05 | 69 | 87 | 4 | 26792178 | |
| Pubmed | 2.95e-05 | 24 | 87 | 3 | 33705438 | ||
| Pubmed | 3.19e-05 | 144 | 87 | 5 | 35681168 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 3.48e-05 | 495 | 87 | 8 | 28581483 | |
| Pubmed | 3.48e-05 | 73 | 87 | 4 | 23464991 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 3.70e-05 | 4 | 87 | 2 | 32616470 | |
| Pubmed | Rapid evolution of human pseudoautosomal genes and their mouse homologs. | 3.70e-05 | 4 | 87 | 2 | 8903724 | |
| Pubmed | Human-Specific ARHGAP11B Acts in Mitochondria to Expand Neocortical Progenitors by Glutaminolysis. | 3.70e-05 | 4 | 87 | 2 | 31883789 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 22423112 | ||
| Pubmed | Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. | 3.70e-05 | 4 | 87 | 2 | 31489369 | |
| Pubmed | The ADP/ATP translocase drives mitophagy independent of nucleotide exchange. | 3.70e-05 | 4 | 87 | 2 | 31618756 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 11287411 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 3.70e-05 | 4 | 87 | 2 | 37141091 | |
| Pubmed | 4.00e-05 | 151 | 87 | 5 | 18457437 | ||
| Pubmed | 4.47e-05 | 513 | 87 | 8 | 25798074 | ||
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 4.60e-05 | 256 | 87 | 6 | 35777956 | |
| Pubmed | 4.73e-05 | 28 | 87 | 3 | 20736409 | ||
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 4.80e-05 | 258 | 87 | 6 | 21081666 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 6.05e-05 | 84 | 87 | 4 | 25670202 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 6.05e-05 | 269 | 87 | 6 | 30442662 | |
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 8825650 | ||
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 24793696 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 6.16e-05 | 5 | 87 | 2 | 11401426 | |
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 15451373 | ||
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 17332328 | ||
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 11296258 | ||
| Pubmed | H+ transport is an integral function of the mitochondrial ADP/ATP carrier. | 6.16e-05 | 5 | 87 | 2 | 31341297 | |
| Pubmed | 7.00e-05 | 547 | 87 | 8 | 37267103 | ||
| Pubmed | 7.46e-05 | 407 | 87 | 7 | 12693553 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | DHX36 RUVBL1 SLC25A4 SLC25A5 SLC25A6 GLUD1 PSMC6 HADHA SNRNP200 | 7.59e-05 | 714 | 87 | 9 | 28302793 |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 8.03e-05 | 558 | 87 | 8 | 35063084 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DHX36 IBTK SLC25A4 SLC25A5 SLC25A6 UBR4 GLUD1 RCL1 PSMC6 SPIRE1 HADHA MARK2 CUL7 | 8.64e-05 | 1496 | 87 | 13 | 32877691 |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 8.81e-05 | 288 | 87 | 6 | 31501420 | |
| Pubmed | Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease. | 9.22e-05 | 6 | 87 | 2 | 23666762 | |
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 9.22e-05 | 6 | 87 | 2 | 35324301 | |
| Interaction | MAP1B interactions | CACNA1A GABRR1 RUVBL1 SLC25A4 SLC25A5 SLC25A6 UBR4 GLUD1 LRRK2 HADHA CUL7 SNRNP200 | 1.79e-06 | 539 | 82 | 12 | int:MAP1B |
| Interaction | TOP3B interactions | TINAGL1 IBTK RIOK1 PTPRF TULP4 XPO5 MYO7A KLHL36 UBR4 MARK4 INTS1 CUL9 SPIRE1 HADHA BCAM REV3L LYN GBA2 TBC1D9 | 5.18e-06 | 1470 | 82 | 19 | int:TOP3B |
| Interaction | SIRT4 interactions | 2.85e-05 | 15 | 82 | 3 | int:SIRT4 | |
| Interaction | TNPO1 interactions | 3.47e-05 | 306 | 82 | 8 | int:TNPO1 | |
| Interaction | PAK1 interactions | 4.12e-05 | 229 | 82 | 7 | int:PAK1 | |
| Cytoband | Yp11.3 | 4.09e-04 | 16 | 86 | 2 | Yp11.3 | |
| Cytoband | 2p23 | 4.63e-04 | 17 | 86 | 2 | 2p23 | |
| Cytoband | 6p21.1 | 4.70e-04 | 80 | 86 | 3 | 6p21.1 | |
| Cytoband | 4q31.21 | 1.09e-03 | 26 | 86 | 2 | 4q31.21 | |
| GeneFamily | Solute carriers | 2.59e-04 | 395 | 58 | 7 | 752 | |
| GeneFamily | Cullins | 2.80e-04 | 8 | 58 | 2 | 1032 | |
| GeneFamily | Kelch like|BTB domain containing | 3.29e-04 | 42 | 58 | 3 | 617 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 8.98e-04 | 134 | 58 | 4 | 861 | |
| GeneFamily | INO80 complex |SRCAP complex | 1.03e-03 | 15 | 58 | 2 | 595 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.67e-03 | 19 | 58 | 2 | 563 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.13e-03 | 26 | 58 | 2 | 253 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 2.92e-06 | 200 | 81 | 7 | M6621 | |
| Coexpression | XU_GH1_AUTOCRINE_TARGETS_UP | 3.02e-06 | 201 | 81 | 7 | M10664 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1A FNBP1 CACNA1E RIPOR2 SLC4A8 ATP8A1 RAPH1 TULP4 MYO7A SCN3A LRRK2 KIF3C REV3L TBC1D9 | 6.79e-06 | 1106 | 81 | 14 | M39071 |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP | 2.61e-05 | 188 | 81 | 6 | M6167 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.52e-06 | 195 | 81 | 6 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 195 | 81 | 6 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 195 | 81 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Monocytes,_Macrophages|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.66e-06 | 198 | 81 | 6 | 7490b30462d03b5edee3bcacdef9483dd15821b5 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.66e-06 | 198 | 81 | 6 | 4f86ff6ba8cbe987e7541fca4f3ae8d0e434677d | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 1.66e-06 | 198 | 81 | 6 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.66e-06 | 198 | 81 | 6 | 82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.71e-06 | 199 | 81 | 6 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.56e-06 | 139 | 81 | 5 | 7c02caed5b9baf233bd6fb9a453708b3e157c790 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-06 | 152 | 81 | 5 | b750302d442160a1007659c2386ac90282bf95d2 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 154 | 81 | 5 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.74e-06 | 156 | 81 | 5 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 163 | 81 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 163 | 81 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 164 | 81 | 5 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 169 | 81 | 5 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 169 | 81 | 5 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 170 | 81 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.79e-05 | 177 | 81 | 5 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.89e-05 | 179 | 81 | 5 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 180 | 81 | 5 | eedb6d89680f968167afb1dcd132c9de9096b50f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 180 | 81 | 5 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 181 | 81 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 184 | 81 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 184 | 81 | 5 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 184 | 81 | 5 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 184 | 81 | 5 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 185 | 81 | 5 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-05 | 185 | 81 | 5 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-05 | 186 | 81 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 186 | 81 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 186 | 81 | 5 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.27e-05 | 186 | 81 | 5 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-05 | 187 | 81 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-05 | 187 | 81 | 5 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 188 | 81 | 5 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 188 | 81 | 5 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 188 | 81 | 5 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 81 | 5 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.45e-05 | 189 | 81 | 5 | b8cbfc47f3f40b6fccd15899d58c87d07b0001aa | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 81 | 5 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.58e-05 | 191 | 81 | 5 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 81 | 5 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.65e-05 | 192 | 81 | 5 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 2.71e-05 | 193 | 81 | 5 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 194 | 81 | 5 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | control-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.78e-05 | 194 | 81 | 5 | a5284adca931a78b1c4592925c4860853ebd24f1 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.78e-05 | 194 | 81 | 5 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.78e-05 | 194 | 81 | 5 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.85e-05 | 195 | 81 | 5 | 2cb435dae2691e1250e26e59f9b8fb652a0c383e | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.85e-05 | 195 | 81 | 5 | 217908cb53016a6cb51f1bc3fc752c8df650df71 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 195 | 81 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.92e-05 | 196 | 81 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 2.92e-05 | 196 | 81 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.99e-05 | 197 | 81 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-05 | 197 | 81 | 5 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.99e-05 | 197 | 81 | 5 | 4d3670456655248250d156f92de01df4aa481733 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 197 | 81 | 5 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue | 2.99e-05 | 197 | 81 | 5 | dcf0009057576a7db9065e644a3919d6de2ac8e6 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.07e-05 | 198 | 81 | 5 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 198 | 81 | 5 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 198 | 81 | 5 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 198 | 81 | 5 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 198 | 81 | 5 | f006d68e6c51923be7772eea118546a5762e8a5e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 198 | 81 | 5 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.14e-05 | 199 | 81 | 5 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 199 | 81 | 5 | 0a9783808528bc4c6d797d849a9177330c8fb867 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.22e-05 | 200 | 81 | 5 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-05 | 127 | 81 | 4 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 143 | 81 | 4 | 57ee1830d96d73d92b5f83b028592a5d952c6013 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 146 | 81 | 4 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 149 | 81 | 4 | a6e192bf9bcf3b219e618c465bc451f7c86f49f1 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage-B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.70e-04 | 152 | 81 | 4 | 5ce8920aedd39a4daf7082153b5e213707c14227 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-04 | 153 | 81 | 4 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 157 | 81 | 4 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | COPD-Epithelial-PNEC|COPD / Disease state, Lineage and Cell class | 2.02e-04 | 159 | 81 | 4 | 6018124980c55190928409f3bf41d846a118954a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 160 | 81 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 160 | 81 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-04 | 161 | 81 | 4 | f50e91f8363f20bb7c565aaca4d4961d3fe4b5b5 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.17e-04 | 162 | 81 | 4 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.17e-04 | 162 | 81 | 4 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.17e-04 | 162 | 81 | 4 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.28e-04 | 164 | 81 | 4 | 49733a9d3d95f05056b5b01916060ff20a8de3cf | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 164 | 81 | 4 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-04 | 165 | 81 | 4 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.33e-04 | 165 | 81 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.33e-04 | 165 | 81 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 166 | 81 | 4 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 166 | 81 | 4 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 167 | 81 | 4 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 2.49e-04 | 168 | 81 | 4 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 2.49e-04 | 168 | 81 | 4 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 2.49e-04 | 168 | 81 | 4 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-04 | 169 | 81 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 169 | 81 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 170 | 81 | 4 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 170 | 81 | 4 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 170 | 81 | 4 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| Drug | oleoylcarnitine | 2.27e-09 | 16 | 82 | 5 | CID006441392 | |
| Drug | Clodronate | 4.50e-08 | 3 | 82 | 3 | DB00720 | |
| Drug | AC1L193Y | 1.26e-07 | 65 | 82 | 6 | CID000000380 | |
| Drug | dehydroabietylamine | 1.80e-07 | 4 | 82 | 3 | ctd:C000600819 | |
| Drug | beta-hydroxypalmitoyl-CoA | 3.59e-07 | 17 | 82 | 4 | CID000440600 | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; HL60; HT_HG-U133A | 5.84e-07 | 198 | 82 | 8 | 6160_UP | |
| Drug | closantel | 1.56e-06 | 7 | 82 | 3 | ctd:C023342 | |
| Drug | n-propionyl-CoA | 2.32e-06 | 166 | 82 | 7 | CID000001033 | |
| Drug | gabapentin | 2.61e-06 | 169 | 82 | 7 | CID000003446 | |
| Drug | AC1LCVTP | 4.33e-06 | 118 | 82 | 6 | CID000656983 | |
| Drug | AC1L4X2K | 5.31e-06 | 10 | 82 | 3 | CID000193824 | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 6.93e-06 | 196 | 82 | 7 | 3857_DN | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 7.17e-06 | 197 | 82 | 7 | 5565_UP | |
| Drug | ME-34 | 1.28e-05 | 2 | 82 | 2 | CID000084012 | |
| Drug | racephenicol | 1.29e-05 | 40 | 82 | 4 | CID000005433 | |
| Drug | nickel | CACNA1A CACNA1E TRPM3 PLCB2 HMOX1 BCAM REV3L CPT1B GBA2 ADCY2 | 2.89e-05 | 552 | 82 | 10 | CID000000934 |
| Drug | carbachol | CACNA1A CACNA1E TRPM3 MLNR MLN PLCB2 MARK2 NMBR CPT1B LYN ADCY2 | 3.53e-05 | 688 | 82 | 11 | CID000002551 |
| Drug | AC1L1D9R | 3.56e-05 | 103 | 82 | 5 | CID000002254 | |
| Drug | carboxyatractyloside | 3.84e-05 | 3 | 82 | 2 | ctd:C003853 | |
| Drug | sevoflurane | 3.90e-05 | 105 | 82 | 5 | CID000005206 | |
| Drug | Ptpc | 4.63e-05 | 55 | 82 | 4 | CID003036276 | |
| Drug | agaric acid | 4.91e-05 | 20 | 82 | 3 | CID000012629 | |
| Drug | phenylsuccinate | 5.71e-05 | 21 | 82 | 3 | CID000095459 | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A | 6.46e-05 | 190 | 82 | 6 | 4314_UP | |
| Drug | verapamil | 6.70e-05 | 490 | 82 | 9 | CID000002520 | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 7.24e-05 | 194 | 82 | 6 | 5398_UP | |
| Drug | AC 110 | 7.65e-05 | 4 | 82 | 2 | CID000022860 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 3633_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 5507_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 3019_DN | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 3388_UP | |
| Drug | Azaperone [1649-18-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 3573_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 6976_UP | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 6810_DN | |
| Drug | PHA-00846566E [724718-26-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 7081_UP | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 3754_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; HL60; HG-U133A | 8.57e-05 | 200 | 82 | 6 | 1741_UP | |
| Drug | Ipratropium bromide [22254-24-6]; Down 200; 9.8uM; PC3; HT_HG-U133A | 8.57e-05 | 200 | 82 | 6 | 5823_DN | |
| Drug | LY294002; Up 200; 10uM; HL60; HG-U133A | 8.57e-05 | 200 | 82 | 6 | 361_UP | |
| Drug | adenine | CACNA1E SLC25A41 SLC25A4 SLC25A5 TRPM3 SLC25A6 GLUD1 REV3L ADCY2 | 9.09e-05 | 510 | 82 | 9 | CID000000190 |
| Drug | methionine hydroxy analog | 1.10e-04 | 26 | 82 | 3 | CID000011427 | |
| Drug | 8-azidoethidium | 1.27e-04 | 5 | 82 | 2 | CID002762649 | |
| Drug | EM574 | 1.27e-04 | 5 | 82 | 2 | CID000084019 | |
| Drug | AC1L1AH5 | 1.27e-04 | 215 | 82 | 6 | CID000000986 | |
| Drug | caffeic acid phenethyl ester | 1.31e-04 | 311 | 82 | 7 | ctd:C055494 | |
| Drug | pyruvic acid | 1.45e-04 | 424 | 82 | 8 | CID000001060 | |
| Drug | tetradotoxin | 1.55e-04 | 428 | 82 | 8 | CID000020382 | |
| Drug | Dexrazoxane | 1.69e-04 | 143 | 82 | 5 | ctd:D064730 | |
| Drug | AC1NDLJ6 | 1.70e-04 | 30 | 82 | 3 | CID004627775 | |
| Drug | HCOH (hydroxymethylene) | 1.88e-04 | 31 | 82 | 3 | CID006432217 | |
| Drug | AC1L432Q | 1.90e-04 | 6 | 82 | 2 | CID000177964 | |
| Drug | 3,4-dihydroquinazoline | 1.90e-04 | 6 | 82 | 2 | CID000583065 | |
| Drug | Bongkrekic Acid | 1.90e-04 | 6 | 82 | 2 | ctd:D001865 | |
| Drug | AC1MIWSL | 1.90e-04 | 6 | 82 | 2 | CID003081371 | |
| Drug | alpha-sialylcholesterol | 1.90e-04 | 6 | 82 | 2 | CID000133976 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 7.37e-08 | 4 | 79 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 6.41e-07 | 7 | 79 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 5.16e-06 | 163 | 79 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.12e-05 | 3 | 79 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 4.23e-05 | 4 | 79 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 4.23e-05 | 4 | 79 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 6.42e-05 | 29 | 79 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 1.14e-04 | 35 | 79 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | argininate measurement | 1.96e-04 | 8 | 79 | 2 | EFO_0800055 | |
| Disease | platelet measurement | 2.04e-04 | 315 | 79 | 6 | EFO_0005036 | |
| Disease | Mitochondrial Myopathies | 3.83e-04 | 11 | 79 | 2 | C0162670 | |
| Disease | meningitis | 3.83e-04 | 11 | 79 | 2 | MONDO_0021108 | |
| Disease | hyperinsulinism (is_implicated_in) | 4.59e-04 | 12 | 79 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 5.42e-04 | 13 | 79 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 5.42e-04 | 13 | 79 | 2 | C1261502 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 7.27e-04 | 15 | 79 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Tremor, Rubral | 8.29e-04 | 16 | 79 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 8.29e-04 | 16 | 79 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 8.29e-04 | 16 | 79 | 2 | C0278161 | |
| Disease | Abnormal coordination | 8.29e-04 | 16 | 79 | 2 | C0520966 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 8.29e-04 | 16 | 79 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | Ataxia, Truncal | 8.29e-04 | 16 | 79 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 8.29e-04 | 16 | 79 | 2 | C0240991 | |
| Disease | Paroxysmal atrial fibrillation | 8.30e-04 | 156 | 79 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 8.30e-04 | 156 | 79 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 8.30e-04 | 156 | 79 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 9.12e-04 | 160 | 79 | 4 | C0004238 | |
| Disease | white matter lesion progression measurement | 9.26e-04 | 71 | 79 | 3 | EFO_0007746 | |
| Disease | triacylglycerol 56:3 measurement | 1.05e-03 | 18 | 79 | 2 | EFO_0010430 | |
| Disease | arachidonic acid measurement | 2.04e-03 | 25 | 79 | 2 | EFO_0006808 | |
| Disease | Ataxia | 2.04e-03 | 25 | 79 | 2 | C0004134 | |
| Disease | Endogenous Hyperinsulinism | 2.21e-03 | 26 | 79 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 2.21e-03 | 26 | 79 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 2.21e-03 | 26 | 79 | 2 | C1257965 | |
| Disease | amino acid measurement | 2.27e-03 | 678 | 79 | 7 | EFO_0005134 | |
| Disease | acute kidney failure (implicated_via_orthology) | 2.38e-03 | 27 | 79 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | Hyperinsulinism | 2.56e-03 | 28 | 79 | 2 | C0020459 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SMAQRARTMALYNPI | 51 | O00555 | |
| TNERFPLRMSRRGMV | 231 | O43709 | |
| VVSYPFDTVRRRMMM | 226 | P12236 | |
| MVSGMSLRPRVNYLQ | 196 | O71037 | |
| MVSGMSLRPRVNYLQ | 196 | Q902F8 | |
| NMDRMYRSAVRATLP | 116 | P54687 | |
| PSRSNRMEMSIFYVV | 1391 | Q15878 | |
| KAQMPTIERLSMTRY | 356 | P49662 | |
| RSVPLTQAMYRSNRM | 701 | Q86UK0 | |
| LTSYPFDTVRRRMMM | 226 | P05141 | |
| TTMARIRRVYVSGLM | 276 | Q9HDC9 | |
| SAPMMYSRRGVRRTA | 71 | P0C7V0 | |
| MPTMRRTVSEIRSRA | 1 | Q9Y2Q0 | |
| IRGMAYSVRVSPQMA | 191 | Q9Y2P8 | |
| SKARMESMNRPYTSL | 591 | Q70E73 | |
| IMRMRTGTQMPIYVT | 1176 | Q8TEM1 | |
| MMEGSRQTRVSRPYK | 1 | Q8N4N3 | |
| RYRAIVNPMDMQTSG | 141 | P28336 | |
| EMAPYMKRLSRGQTV | 2046 | Q8N201 | |
| FYRKMIPAMDRRVIT | 926 | Q9P2D0 | |
| RPISQYARVAMAMGS | 686 | O14782 | |
| RMIRQTPERILMTYQ | 1106 | P56645 | |
| LYVRDTLQPGMRVRM | 371 | Q14999 | |
| PYRNSMMTSVLRDSL | 296 | Q6ZMV9 | |
| YMQPVMQSDRTAIRS | 281 | Q9P2J3 | |
| ASTLARMVIRYQMKS | 836 | Q5S007 | |
| RMTELSRDMNAYIRP | 196 | Q8IVH4 | |
| LFRIMRNGTILYTMR | 151 | P48169 | |
| LYTMRLTISAECPMR | 161 | P48169 | |
| QYMQRLSTMRTLSNP | 381 | Q4VXU2 | |
| MVSGMSLRPRVNYLQ | 956 | P63135 | |
| RKRRTTEMMPVYLDL | 431 | Q9UII4 | |
| AKMRASVRMTRYLES | 486 | Q08462 | |
| PQRKSQRSSYVSMRI | 436 | P24046 | |
| MMLPYTATLSKRNRE | 261 | Q9Y366 | |
| GRPRSMLRSYRQMSI | 1631 | Q92608 | |
| YVMSRATVRRLQAIM | 281 | Q9C0J1 | |
| LTRRRYLMSGVMAPV | 571 | Q9HCG7 | |
| MVSGMSLRPRVNYLQ | 196 | P61570 | |
| MVSGMSLRPRVNYLQ | 196 | Q69384 | |
| ERRIVRMGESMKTYA | 221 | Q96RU3 | |
| AYTMERSARQIMRTA | 511 | P00367 | |
| RRRYSASTVDVIEMM | 451 | Q9H2U1 | |
| GRMVRYLMRSREITL | 351 | Q96EZ8 | |
| PRRTELMVSMGYTRE | 326 | Q7KZI7 | |
| LPPSMMTRRNTYVCT | 501 | Q96L34 | |
| DVMTALSQGYRMPRV | 451 | P07948 | |
| YTTRCLAPMMSEVIR | 546 | P40939 | |
| LYRSRMNSLEMTPAV | 181 | P09601 | |
| PTTRTILMMLLNRYS | 911 | Q8IWT3 | |
| SKMVPAYRMQSPRAL | 86 | O96002 | |
| MYRMKRSQVRTPIRR | 1 | Q5VT33 | |
| MVSGMSLRPRVNYLQ | 196 | Q902F9 | |
| VEMNPEGYMTSRTVR | 196 | P50895 | |
| FRTPVYTTSMRRNAM | 4426 | Q8IVF4 | |
| TIDRVGRIYPMAMSN | 396 | O15245 | |
| SYQMERMFNTTRIPG | 306 | Q92523 | |
| NVVTVMLIGRYRDMR | 56 | O43193 | |
| MLIGRYRDMRTTTNL | 61 | O43193 | |
| PPRRVQARMLSASTM | 416 | P10586 | |
| SAQRTPVQMMYLREK | 226 | P05120 | |
| MDYRRLLMSRVVPGQ | 1 | Q9BRS2 | |
| YRLGTIRPSSSVMNM | 176 | Q9GZM7 | |
| RMSRMQSKEYPVVPR | 246 | Q99593 | |
| RRFSGQPRSIMERIM | 161 | Q96K19 | |
| GQMASYPLTLVRTRM | 296 | Q8N5S1 | |
| VRKRRLSSYQISMEM | 681 | Q9NY46 | |
| RARMAVTPKEMYSNI | 156 | Q86VD7 | |
| KTSRYFPTRVRSMVS | 716 | Q2Y0W8 | |
| LQRRMSMYSQGTPET | 336 | Q9Y4F9 | |
| LVSYPFDTVRRRMMM | 226 | P12235 | |
| RQMTIYLPEVRKISM | 636 | Q9NRJ4 | |
| PVRGARNQLRMYLTM | 281 | Q5BJH7 | |
| DTQTMESRGLRRYIM | 2551 | Q8N2C7 | |
| GMRMNSRQLEKYPAT | 86 | P12872 | |
| TRGSQYRVESMMLRI | 2556 | O60673 | |
| IRRSRLAMRPLSMSY | 391 | Q08AE8 | |
| RDVVRPYQTMSNPMS | 266 | Q9HCF6 | |
| VPTATQTLMTMYRRR | 456 | Q6ZT07 | |
| QTLMTMYRRRSPEEF | 461 | Q6ZT07 | |
| MVSGMSLRPRVNYLQ | 956 | P10266 | |
| AVTVMMDPNSTQRYR | 16 | Q9HAV4 | |
| NKRQMSRIYPKGTRM | 596 | Q00722 | |
| DRVMIIRTMLYTPQE | 356 | Q9Y265 | |
| MVYVTQSAGRLMRAI | 1081 | O75643 | |
| DMTTLTIMRYLPREV | 101 | P62333 | |
| TTNEGEPMRIVYRMR | 4431 | Q5T4S7 | |
| MCFIRTTRPETMVIY | 441 | P51854 | |
| SIRVPREKMVYMTVN | 286 | P08048 | |
| SRSPMLQRRVYHSMA | 476 | Q96NJ5 | |
| LRYSGMMETIRIRRA | 656 | Q13402 | |
| MMETIRIRRAGYPIR | 661 | Q13402 | |
| SMRSMQHSPNLRTYR | 946 | O76041 |